<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>insulin aspart</title><link>http://www.unboundmedicine.com/medline/ebm/research/insulin_aspart</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922879/full_citation/Comparison_of_insulin_detemir_and_insulin_glargine_in_a_basal_bolus_regimen_with_insulin_aspart_as_the_mealtime_insulin_in_patients_with_type_1_diabetes:_A_52_week_multinational_randomized_open_label_parallel_group_Treat_to_Target_noninferiority_trial_</link><description>Heller S, Koenen C, Bode B <br/><span class="title">Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical therapeutics">Clin Ther 2009 Oct; 31(10):2086-2097.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922879/abstract/Comparison_of_insulin_detemir_and_insulin_glargine_in_a_basal_bolus_regimen_with_insulin_aspart_as_the_mealtime_insulin_in_patients_with_type_1_diabetes:_A_52_week_multinational_randomized_open_label_parallel_group_Treat_to_Target_noninferiority_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922879/full_citation/Comparison_of_insulin_detemir_and_insulin_glargine_in_a_basal_bolus_regimen_with_insulin_aspart_as_the_mealtime_insulin_in_patients_with_type_1_diabetes:_A_52_week_multinational_randomized_open_label_parallel_group_Treat_to_Target_noninferiority_trial_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922879/Comparison_of_insulin_detemir_and_insulin_glargine_in_a_basal_bolus_regimen_with_insulin_aspart_as_the_mealtime_insulin_in_patients_with_type_1_diabetes:_A_52_week_multinational_randomized_open_label_parallel_group_Treat_to_Target_noninferiority_trial_">Find Related Articles</a> </description></item><item><title>Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916727/full_citation/Engineering_study_comparing_injection_force_and_dose_accuracy_between_two_prefilled_insulin_injection_pens_</link><description>Ignaut DA, Opincar MR, Clark PE, et al. <br/><span class="title">Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Current medical research and opinion">Curr Med Res Opin 2009 Dec; 25(12):2829-33.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916727/abstract/Engineering_study_comparing_injection_force_and_dose_accuracy_between_two_prefilled_insulin_injection_pens_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916727/full_citation/Engineering_study_comparing_injection_force_and_dose_accuracy_between_two_prefilled_insulin_injection_pens_">Full Citation</a></description></item><item><title>Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916705/full_citation/Biphasic_insulin_aspart_30_as_insulin_initiation_or_replacement_therapy:_the_China_cohort_of_the_IMPROVE_study_</link><description>Yang W, Gao Y, Liu G, et al. <br/><span class="title">Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current medical research and opinion">Curr Med Res Opin 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916705/abstract/Biphasic_insulin_aspart_30_as_insulin_initiation_or_replacement_therapy:_the_China_cohort_of_the_IMPROVE_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916705/full_citation/Biphasic_insulin_aspart_30_as_insulin_initiation_or_replacement_therapy:_the_China_cohort_of_the_IMPROVE_study_">Full Citation</a></description></item><item><title>Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19900993/full_citation/Combining_insulin_with_metformin_or_an_insulin_secretagogue_in_non_obese_patients_with_type_2_diabetes:_12_month_randomised_double_blind_trial_</link><description>Lund SS, Tarnow L, Frandsen M, et al. <br/><span class="title">Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="BMJ (Clinical research ed.)">BMJ 2009.:b4324.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19900993/abstract/Combining_insulin_with_metformin_or_an_insulin_secretagogue_in_non_obese_patients_with_type_2_diabetes:_12_month_randomised_double_blind_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19900993/full_citation/Combining_insulin_with_metformin_or_an_insulin_secretagogue_in_non_obese_patients_with_type_2_diabetes:_12_month_randomised_double_blind_trial_">Full Citation</a> | <a href="http://bmj.com/cgi/pmidlookup%3fview=long%26amp;pmid=19900993">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19900993/Combining_insulin_with_metformin_or_an_insulin_secretagogue_in_non_obese_patients_with_type_2_diabetes:_12_month_randomised_double_blind_trial_">Find Related Articles</a> </description></item><item><title>A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19854333/full_citation/A_1c__control_in_a_primary_care_setting:_self_titrating_an_insulin_analog_pre_mix__INITIATEplus_trial__</link><description>Oyer DS, Shepherd MD, Coulter FC, et al. <br/><span class="title">A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). [Clinical Trial, Phase IV, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="The American journal of medicine">Am J Med 2009 Nov; 122(11):1043-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19854333/abstract/A_1c__control_in_a_primary_care_setting:_self_titrating_an_insulin_analog_pre_mix__INITIATEplus_trial__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19854333/full_citation/A_1c__control_in_a_primary_care_setting:_self_titrating_an_insulin_analog_pre_mix__INITIATEplus_trial__">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(09)00667-6">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19854333/A_1c__control_in_a_primary_care_setting:_self_titrating_an_insulin_analog_pre_mix__INITIATEplus_trial__">Find Related Articles</a> </description></item><item><title>Three-year efficacy of complex insulin regimens in type 2 diabetes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19850703/full_citation/Three_year_efficacy_of_complex_insulin_regimens_in_type_2_diabetes_</link><description>Holman RR, Farmer AJ, Davies MJ, et al. <br/><span class="title">Three-year efficacy of complex insulin regimens in type 2 diabetes. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="The New England journal of medicine">N Engl J Med 2009 Oct 29; 361(18):1736-47.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19850703/abstract/Three_year_efficacy_of_complex_insulin_regimens_in_type_2_diabetes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19850703/full_citation/Three_year_efficacy_of_complex_insulin_regimens_in_type_2_diabetes_">Full Citation</a> | <a href="http://content.nejm.org/cgi/pmidlookup%3fview=short%26amp;pmid=19850703%26amp;promo=ONFLNS19">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19850703/Three_year_efficacy_of_complex_insulin_regimens_in_type_2_diabetes_">Find Related Articles</a> </description></item><item><title>Time-Action Profile and Patient Assessment of Inhaled Insulin via the Exubera Device in Comparison with Subcutaneously Injected Insulin Aspart via the FlexPen Device.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19848574/full_citation/Time_Action_Profile_and_Patient_Assessment_of_Inhaled_Insulin_via_the_Exubera_Device_in_Comparison_with_Subcutaneously_Injected_Insulin_Aspart_via_the_FlexPen_Device_</link><description>Forst T, Hohberg C, Schöndorf T, et al. <br/><span class="title">Time-Action Profile and Patient Assessment of Inhaled Insulin via the Exubera Device in Comparison with Subcutaneously Injected Insulin Aspart via the FlexPen Device. [Journal Article]</span><br/><span class="source" title="Diabetes technology &amp; therapeutics">Diabetes Technol Ther 2009 Feb; 11(2):87-92.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19848574/abstract/Time_Action_Profile_and_Patient_Assessment_of_Inhaled_Insulin_via_the_Exubera_Device_in_Comparison_with_Subcutaneously_Injected_Insulin_Aspart_via_the_FlexPen_Device_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19848574/full_citation/Time_Action_Profile_and_Patient_Assessment_of_Inhaled_Insulin_via_the_Exubera_Device_in_Comparison_with_Subcutaneously_Injected_Insulin_Aspart_via_the_FlexPen_Device_">Full Citation</a></description></item><item><title>Sliding Scale Versus Tight Glycemic Control in the Noncritically Ill at a Community Hospital(November).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19826097/full_citation/Sliding_Scale_Versus_Tight_Glycemic_Control_in_the_Noncritically_Ill_at_a_Community_Hospital_November__</link><description>Patel GW, Roderman N, Lee KA, et al. <br/><span class="title">Sliding Scale Versus Tight Glycemic Control in the Noncritically Ill at a Community Hospital(November). [JOURNAL ARTICLE]</span><br/><span class="source" title="The Annals of pharmacotherapy">Ann Pharmacother 2009 Oct 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19826097/abstract/Sliding_Scale_Versus_Tight_Glycemic_Control_in_the_Noncritically_Ill_at_a_Community_Hospital_November__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19826097/full_citation/Sliding_Scale_Versus_Tight_Glycemic_Control_in_the_Noncritically_Ill_at_a_Community_Hospital_November__">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19826097/Sliding_Scale_Versus_Tight_Glycemic_Control_in_the_Noncritically_Ill_at_a_Community_Hospital_November__">Find Related Articles</a> </description></item><item><title>Leukocytoclastic vasculitis associated with insulin aspart in a patient with Type 2 diabetes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19825323/full_citation/Leukocytoclastic_vasculitis_associated_with_insulin_aspart_in_a_patient_with_Type_2_diabetes_</link><description>Marusic S, Vlahovic-Palcevski V, Ljubanovic D <br/><span class="title">Leukocytoclastic vasculitis associated with insulin aspart in a patient with Type 2 diabetes. [Journal Article]</span><br/><span class="source" title="International journal of clinical pharmacology and therapeutics">Int J Clin Pharmacol Ther 2009 Oct; 47(10):603-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19825323/abstract/Leukocytoclastic_vasculitis_associated_with_insulin_aspart_in_a_patient_with_Type_2_diabetes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19825323/full_citation/Leukocytoclastic_vasculitis_associated_with_insulin_aspart_in_a_patient_with_Type_2_diabetes_">Full Citation</a></description></item><item><title>Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19821654/full_citation/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_</link><description>Strojek K, Bebakar WM, Khutsoane DT, et al. <br/><span class="title">Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current medical research and opinion">Curr Med Res Opin 2009 Oct 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19821654/abstract/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19821654/full_citation/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19821654/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_">Find Related Articles</a> </description></item></channel></rss>